FAQ

gp34 protein, Murine cytomegalovirus

Known as: gp34 protein, MCMV, m04 protein, MCMV, glycoprotein 34, Murine cytomegalovirus 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1979-2017
02419792017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Preliminary studies on the differential expression of adrenocorticotropic hormone receptor in adrenal adenomas.
INTRODUCTION The ACTH receptor (ACTHR) is primarily expressed in the adrenal cortex. Previous studies focused on the regulatory… (More)
Is this relevant?
2016
2016
Transplant-induced reactivation of murine cytomegalovirus immediate early gene expression is associated with recruitment of NF-κB and AP-1 to the major immediate early promoter.
Reactivation of latent human cytomegalovirus is a significant infectious complication of organ transplantation and current… (More)
Is this relevant?
2015
2015
Cytomegalovirus-Based Vaccine Expressing a Modified Tumor Antigen Induces Potent Tumor-Specific CD8(+) T-cell Response and Protects Mice from Melanoma.
The presence of tumor-infiltrating CD8(+) T cells is associated with tumor regression and better prognosis. Cytomegalovirus (CMV… (More)
Is this relevant?
2013
2013
Cytomegalovirus-based cancer vaccines expressing TRP2 induce rejection of melanoma in mice.
Cytomegalovirus (CMV) induces strong and long-lasting immune responses, which make it an attractive candidate for a cancer… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2010
2010
Immune evasion proteins of murine cytomegalovirus preferentially affect cell surface display of recently generated peptide presentation complexes.
For recognition of infected cells by CD8 T cells, antigenic peptides are presented at the cell surface, bound to major… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 5
  • figure 6
Is this relevant?
2010
2010
A spread-deficient cytomegalovirus for assessment of first-target cells in vaccination.
Human cytomegalovirus (HCMV) is a human pathogen that causes severe disease primarily in the immunocompromised or immunologically… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2009
2009
The spleen plays a central role in primary humoral alloimmunization to transfused mHEL red blood cells.
BACKGROUND Several differences exist between antigens on transfused red blood cells (RBCs) and other immunogens, including… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2008
2008
Restoration of vitamin C synthesis in transgenic Gulo-/- mice by helper-dependent adenovirus-based expression of gulonolactone oxidase.
Inability to synthesize vitamin C, because of a deficiency in gulonolactone oxidase (GULO) expression, is a genetic deficiency… (More)
Is this relevant?
2002
2002
Development of a vaccine against murine cytomegalovirus (MCMV), consisting of plasmid DNA and formalin-inactivated MCMV, that provides long-term, complete protection against viral replication.
We previously demonstrated that immunization of mice with plasmid DNAs (pDNAs) expressing the murine cytomegalovirus (MCMV) genes… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
1979
Review
1979
The murine cytomegalovirus as a model for the study of viral pathogenesis and persistent infections
I have two main reasons for presenting this review on murine cytomegalovirus (MCMV). The first is a response to the increasing… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?